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Immune Cell Dynamics in the CNS: Learning
From the Zebrafish
Nynke Oosterhof,1 Erik Boddeke,2 and Tjakko J. van Ham1
A major question in research on immune responses in the brain is how the timing and nature of these responses influence
physiology, pathogenesis or recovery from pathogenic processes. Proper understanding of the immune regulation of the
human brain requires a detailed description of the function and activities of the immune cells in the brain. Zebrafish larvae
allow long-term, noninvasive imaging inside the brain at high-spatiotemporal resolution using fluorescent transgenic reporters
labeling specific cell populations. Together with recent additional technical advances this allows an unprecedented versatility
and scope of future studies. Modeling of human physiology and pathology in zebrafish has already yielded relevant insights
into cellular dynamics and function that can be translated to the human clinical situation. For instance, in vivo studies in the
zebrafish have provided new insight into immune cell dynamics in granuloma formation in tuberculosis and the mechanisms
involving treatment resistance. In this review, we highlight recent findings and novel tools paving the way for basic neuroim-
munology research in the zebrafish.
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Introduction
It is well established that the immune system plays an impor-tant role in brain homeostasis and most conditions affecting
the brain, including neurodegenerative diseases, psychiatric dis-
eases and neurodevelopmental disorders (Lucin and Wyss-Coray,
2009; Prinz and Priller, 2014; Schwartz et al., 2013). Our cur-
rent understanding of neuroimmunology, the complex interac-
tions of the immune system with the central nervous system
(CNS), however, is limited and many fundamental questions are
still unanswered. Basic questions concerning the ontogeny of the
brain’s immune cells and glia, their functional phenotypes, the
life-span of brain immune cells and the effect of aging remain
to be answered and are essential for a better understanding of
the role of the immune system in CNS health and disease
(Streit, 2006; Ginhoux et al., 2013; Biber et al., 2014).
A prerequisite for a more comprehensive description of
immunological processes in the brain is a thorough characteri-
zation of the function of the different types of immune cells
involved. This can be achieved in animal model systems by
long-term visualization and mapping of neuroimmune cellular
dynamic interactions in the living brain.
In the last decade, the zebrafish has gained substantial
popularity as a model for basic research as well as transla-
tional biomedical research. Also in neuroscience research, the
use of zebrafish as a model is now quickly gaining momen-
tum. Recent technical advances including genome editing
(Hwang et al., 2013; Sander et al., 2011; Schmid and Haass,
2013), optogenetics (Teh et al., 2010; Weber and Koster,
2013), fluorescent imaging tools (Giepmans et al., 2006;
Mickoleit et al., 2014), and high-throughput behavioral
screens have highlighted the use of zebrafish in understanding
brain development and function and sped up the discovery of
novel psychoactive drugs (Kokel et al., 2010; Rihel et al.,
2010).
An important use of zebrafish in biomedical research, is
the very powerful possibility for in vivo high-resolution imag-
ing of dynamic cellular and even subcellular pathogenic
mechanisms in transparent larvae. This has yielded detailed in
vivo mechanistic insight into developmental and disease proc-
esses, including tissue regeneration (Andersson et al., 2012;
Zhang et al., 2013), various types of cancer (Chapman et al.,
2014; Feng et al., 2010; Langenau et al., 2005; Stoletov
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et al., 2010) and infectious disease (Colucci-Guyon et al.,
2011; Davis et al., 2002; Tobin et al., 2012). Although a sim-
ilar level of in depth genetic, cellular and molecular under-
standing in neuroimmunology is still far away, this is clearly
feasible. Comparable imaging of in vivo cell biology at
micron-scale level is hard to achieve in the human brain or in
classical mammalian models. Clearly, knowledge about these
cellular dynamics may be essential to better understand and
eventually treat brain diseases.
The main purpose of this review is not as much to give
a summary of recent studies but to illustrate the unique appli-
cation of the zebrafish for detailed long-term monitoring of
motile immune cells in the healthy CNS as well as in a dis-
ease context. To do so, we will make a case for the specific
niche the zebrafish occupies as a discovery platform in the
field of neuroimmunology and brain disease research to help
resolve in vivo mechanisms that are unlikely to be studied in
another way. Data derived from these zebrafish studies are in
general complementary to studies in other animal models
rather than redundant, help to generate hypotheses, provide
unexpected novel in vivo insights, and sometimes allow for
very rapid preclinical development.
First, we will provide background on the conservation
of the zebrafish CNS and immune system, relevant to con-
sider the strengths and weaknesses of zebrafish as model for
neuroinflammation. Subsequently, we will describe illustrative
examples of studies using zebrafish showing how conceptual
questions can be addressed yielding unexpected in vivo insight
in disease-related mechanisms, with sometimes direct clinical
relevance. We conclude by consolidating recent technical
advances to illustrate what this has yielded so far, and provide
several examples already showing the tremendous potential
and technical possibilities to address some of the main ques-
tions related to functions and origins of immune cells in the
brain.
Hereby this review should provide convincing argu-
ments to apply the zebrafish as a tool, allowing an unprece-
dented view into functions of cellular behavior and
contribution to pathogenic mechanisms with the realistic pos-
sibility of extrapolating basic findings to patients. Although
linear translation of a human CNS disease to zebrafish and
back may often not be possible, relevant insights into
immune cell dynamics related to such CNS diseases as well as
discovering novel concepts that can be translated to more
clinical models is very well achievable.
The Zebrafish as an In Vivo Model for Human
Disease
The zebrafish, a small teleost fish native to streams of the
south eastern Himalaya, was first introduced as a model orga-
nism for developmental biology by George Streisinger in the
late 1960s, mainly because of its rapid, completely external
embryonic development (Streisinger et al., 1981). Within
24 h after fertilization several organs and cell types, have
formed, and are already functioning including the heart, cir-
culation and early innate immune cells capable of ingesting
dying cells and bacterial pathogens (Herbomel et al., 1999).
Behaviors requiring interactions between different neuronal
circuits, such as hunting and capturing prey animals, also
develop within the first days of development (Bianco et al.,
2011; Budick and O’Malley, 2000; Muto and Kawakami,
2013). Because of their transparency, small size, and rapid
development of organs and tissue including the CNS and the
immune system zebrafish embryos and larvae have been used
extensively for in vivo imaging studies of organ development
and behavioral research.
The Zebrafish Brain
In vertebrates, including the zebrafish, the embryonic devel-
opment of the CNS involves formation of the neural tube,
which subsequently folds in an intricate manner, creating
more distinct fore-, mid-, and hindbrain regions. Eventually,
by cell-migration and differentiation these regions further
develop into the cerebrum, thalamus and hypothalamus, tec-
tum, tegmentum, cerebellum, pons, and medulla (Blader
and Strahle, 2000; Wilson et al., 2002). The main vertebrate
cell types in the mammalian CNS, including neurons and
glial cells, such as oligodendrocytes, microglia (Fig. 1B,D;
Table 1) and astrocytes, have been identified in the zebra-
fish, as well as specialized barrier structures such as the
blood–brain barrier (BBB) and the choroid plexus (Fleming
et al., 2013; Garcia-Lecea et al., 2008; Herbomel et al.,
2001; Marcus and Easter, 1995; Park et al., 2002; Peri and
Nusslein-Volhard, 2008). Main inhibitory as well as excita-
tory neurotransmitter systems, including GABAergic, gluta-
matergic, cholinergic, dopaminergic and serotonergic
neurotransmission are highly conserved at all levels in the
zebrafish (Panula et al., 2010).
Abbreviations
APC antigen presenting cell
BBB blood brain barrier
CNS central nervous system
CreERT2 Cre recombinase—estrogen receptor T2
EAE experimental autoimmune encephalitis
FP fluorescent protein
GFAP glial fibrillary acidic protein
GFP green fluorescent protein
Mhc major histocompatibility complex
NLR NOD-like receptor
NTR nitroreductase
SGZ subgranular zone
SVZ subventricular zone
TILLING Targeting induced local lesions in genomes
TLR Toll-like receptor
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FIGURE 1: Conserved anatomic features of the brain in vertebrates and conserved microglial morphology and behavior. (A), (C) Sche-
matic representations of the mouse (top) and zebrafish brain (bottom). FB5 forebrain, OB5olfactory bulb, Tel5 telencephalon,
MB5midbrain, HB5hindbrain, and CB5 cerebellum. (B) Mouse brain sections showing Iba1 antibody-stained microglia in ramified (left)
and activated state (right). (D) Zebrafish brain sections showing L-plastin antibody-stained microglia (left) in ramified and activated,
amoeboid state (right). (E) 5-day-old zebrafish larva. (F) Stills of confocal microscopic time-lapse recording showing engulfment of an
apoptotic neuron (magenta, neuronal red fluorescent protein) by a microglia cell (green, microglial green fluorescent protein) in the
brain of a 3-day-old zebrafish larva.
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Although most basic anatomical regions, cells, and neu-
rotransmitters are conserved between zebrafish and mammals,
there are a few important differences (Fig. 1A,B; Tables 1 and
2). For example, fish have nociceptive pathways and respond
to noxious stimuli but it is still unclear whether fish can per-
ceive pain, which is considered to be a higher cognitive pro-
cess (Malafoglia et al., 2013). The neocortex, arguably the
most distinguishing feature of the human brain, is thought to
be exclusively found in mammals. Fish only have a primitive
cerebral brain structure lacking these regions important for
higher cognitive functions. However, higher cognitive proc-
esses have been described in birds and reptiles suggesting
TABLE 1: Conservation of the CNS and immune sys-
tem between mammals (e.g., human) and teleosts (e.g.,
zebrafish)
Mammals Zebrafish
CNS
Main structures
Forebrain (cerebrum,
thalamus, hypothalamus)
1 1
Midbrain (tectum,
tegmentum)
1 1
Hindbrain (cerebellum,
pons, medulla)
1 1
Blood brain barrier 1 1
Meninges 1 1
Choroid plexus 1 1
Ventricular system 1 1
CNS cell types
Neurons 1 1
Oligodendrocytes 1 1
Astrocytes 1 1/-
Microglia 1 1
Major neurotransmitter systems
Amino acids (glutamate,
GABA, glycine)
1 1
Monoamines (dopamine,
serotonin)
1 1
Peptides (somatostatin,
opioids)
1 1
Other (acetylcholine) 1 1
Immune system
Main structures
Thymus 1 1
Bone marrow 1 -
Lymph nodes & antigen
presentation
1 1/-
Lymphatic system 1 1
Leukocytes
Mononuclear phagocytes
(monocytes, macrophage, APCs)
1 1
Granulocytes (neutrophils,
eosinophils)
1 1
Lymphocytes (T cells, B
cells, NK cells)
1 1/-
TABLE 1: Continued
Mammals Zebrafish
Molecular components
Myeloid differentiation
(PU.1, IRF8, CSF1R)
1 1
PRRs (Pattern recognition
receptors e.g. TLRs)
1 1
Complement cascade 1 1
Transcription factors (NFjB) 1 1
Antigen presentation
(MHC II)
1 1
Cytokine signaling
(IL-1b, IL-4, IL-10, IL-6,
TGFb, IFNg, TNFa)
1 1
Chemokine signaling 1 1
Major structures, cell types and molecular pathways in the CNS
and immune system share a high level of conservation between
mammals and teleosts (e.g., zebrafish). Some of the differences
indicated in this table are in fact not as distinct when viewed
from a different perspective. Although zebrafish have no hemato-
poietic bone marrow, hematopoiesis occurs largely in the kidney
marrow, which is at least to a large extent functionally equivalent
to the mammalian bone marrow. The same applies to lymph
nodes: although lymph nodes are absent in fish, antigen presen-
tation, the main function of lymph nodes, occurs by antigen pre-
senting cells but elsewhere. Although teleosts exhibit a blood
brain barrier, the meninges is structurally different from mam-
mals. In mammals the meninges consists of three layers, whereas
in teleost only one membranous layer is present known as the
primitive meninx. With regard to genetic conservation, it is
important to note that a an ancient genome duplication occurred
in teleosts. Therefore, it is estimated that 30% of genes have a
duplicate variant, that may or may not exhibit redundancy and
share the same function. Second, although main immune signal-
ing pathways are highly conserved even across invertebrates, in
particular the situation for chemokines is more complex, as they
differ quite extensively (Bajoghli, 2013; Nomiyama et al., 2008).
In fact even among mammals several chemokines are not con-
served at the sequence level, and functional homologs remain to
be identified.
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there likely is functional conservation located elsewhere. Simi-
larly, the dorsal pallium in nonmammalian vertebrates is
thought to provide functions equivalent to the mammalian
hippocampus, for example with regard to spatial navigation
(Kempermann, 2012).
Another major difference is the high abundance of neuro-
genic zones in the adult zebrafish brain and their high regenera-
tive capacity, which in the adult mammalian CNS is thought to
be mainly restricted to the subventricular zone (SVZ) and sub-
granular zone (SGZ; Grandel and Brand, 2013). One interesting
line of thought, suggests that the strong regenerative capacity of
the nonmammalian vertebrate CNS may have become repressed
in mammals during evolution (Powell et al., 2013). An interest-
ing finding, which supports this idea is a study by Powell and
colleagues, who showed correlation between DNA demethyla-
tion and regeneration-associated gene expression in a zebrafish
model for retinal injury. In particular methylated promoter
regions of genes important for regeneration were demethylated
in regenerating retina, whereas the same regions in mammals
were not (Powell et al., 2013). This suggests that the zebrafish
could be suitable for identifying regenerative programs that
could possibly be switched on in adult mammals as a potential
therapeutic option in traumatic brain injury, brain damage aris-
ing from stroke, and other diseases involving loss of neurons.
Zebrafish Immunity
Most major human immune cell lineages, such as macro-
phages, neutrophils, lymphocytes-B, and T cells, have been
identified in the zebrafish (Page et al., 2013; Renshaw and
Trede, 2012; Trede et al., 2004). The development of zebra-
fish immune cells follows a similar differentiation trajectory
and is controlled by a similar transcriptional program as
found in mammals, involving waves of primitive and defini-
tive hematopoiesis (Ellett and Lieschke, 2010). During primi-
tive hematopoiesis, cells of the intermediate cell mass, the
zebrafish equivalent of the primitive blood islands in the
mammalian yolk sac, become either myeloid lineage cells or
erythroid cells. This decision depends on Pu.1 and Gata1-
dependent transcriptional activity, respectively, similar to
mammals (Belele et al., 2009; Ellett and Lieschke, 2010).
During definitive hematopoiesis, starting 1-day postfertiliza-
tion, hematopoietic stem cells (HSCs) are formed which
expand into erythroid lineage cells and other myeloid lineage
cells (Davidson and Zon, 2004; Ellett and Lieschke, 2010).
The adaptive branch of the immune system develops at
a later stage which allows a window in which the innate
immune system can be studied without involvement of the
adaptive system. In zebrafish generation of lymphocytes—
lymphopoiesis—starts around 3 days after fertilization (Lange-
nau and Zon, 2005; Willett et al., 1999, 2001). One major
difference between the fish and mammalian adaptive immune
system is the absence of lymph nodes in fish species in gen-
eral (Isogai et al., 2009). However, zebrafish do have a reper-
toire of major histocompatibility complex II (MhcII)
expressing antigen presenting cells, B- and T-lymphocytes and
a lymphatic system, showing that functional components of
the adaptive immune system are present (Langenau and Zon,
2005; Lewis et al., 2014; Renshaw and Trede, 2012; Yaniv
et al., 2006). Quintana et al. (2010) demonstrated that the
zebrafish has active mechanisms of self-tolerance by showing
that the zebrafish ortholog for mammalian Foxp3 (zFoxp3),
which is involved in the regulation of self-tolerance,
TABLE 2: Online zebrafish resources
Organization/Resource Website
Zebrafish Information Network (ZFIN) ZFIN.org
Zebrafish International resource center (ZIRC) zirc.org
European zebrafish resource center (EZRC) ezrc.kit.edu
National BioResource Project Zebrafish http://www.shigen.nig.ac.jp/zebra/index_en.html
Zebrafish Disease Models Society www.zdmsociety.org
Zebrafish Mutation Project (Sanger Institute) sanger.ac.uk/Projects/D_rerio/zmp/
Zebrafish Brain Atlas zebrafishbrain.org
Zebrafish Atlas zfatlas.psu.edu/index.php
Zebrafish Genome (Ensembl) www.ensembl.org/Danio_rerio/Info/Index
Zebrafish Genome (Sanger) sanger.ac.uk/resources/zebrafish/genoproject.html
Zebrafish Genome (NCBI) ncbi.nlm.nih.gov/genome?term5danio%20rerio
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controlled expression of IL-17, which is associated with auto-
immune pathology in mammals. Furthermore, zFoxp3
induced a regulatory phenotype on mouse T-cells, indicating
that zFoxp3 has a similar function as mammalian Foxp3
(Quintana et al., 2010). This suggests that the adaptive
immune system in the zebrafish has fundamental similarities
with mammalian adaptive immunity.
In addition to immune cell types, many of the mamma-
lian immune receptor classes (e.g., TLRs, NLRs), signaling
pathways and inflammatory mediators (e.g., interleukins,
complement) are conserved in the zebrafish (Hall et al.,
2009; Meijer and Spaink, 2011; van der Vaart et al., 2013;
Zhang and Cui, 2014; Tables 1 and 2). Furthermore, cellular
responses to different immune challenges such as pathogens
(Stockhammer et al., 2009; Torraca et al., 2014; Volkman
et al., 2010), wounding (Yoo et al., 2011), and cancer (Feng
et al., 2012) are similar. With regard to genetic conservation,
it is important to note that an ancient genome duplication
has occurred in teleosts. Therefore, it is estimated that 30%
of genes have a duplicate variant, that may or may not exhibit
redundancy and share the same function (Postlethwait et al.,
2000). Second, although several main immune signaling path-
ways are highly conserved even across invertebrates, for exam-
ple TLRs were discovered in fruit flies, the situation for
chemokines in particular is a bit more complicated. Chemo-
kine signaling molecules differ quite extensively between
mammals and teleosts (Bajoghli, 2013; Nomiyama et al.,
2008). In fact even among mammals several chemokines are
not conserved at the sequence level, and many functional
homologs remain to be identified in the zebrafish.
Zebrafish CNS Immune Cells
Microglia are the resident immune cells of the CNS. They
develop from primitive yolk sac-derived macrophages which
colonize the CNS during embryogenesis and differentiate into
microglia in a Spi1/Pu.1-transcription factor dependent man-
ner (Herbomel et al., 1999, 2001). Interestingly, this process
was identified in the zebrafish about a decade before an anal-
ogous Spi1/Pu.1-dependent process, was identified in mam-
mals (Ginhoux et al., 2010; Kierdorf et al., 2013). Similar to
mammalian microglia, zebrafish microglia are ramified cells
(Fig. 1C,D) with dynamic processes that are scanning their
environment. Upon infection or injury they can immediately
respond by migrating to the relevant site, and are capable of
efficiently phagocytizing bacteria and neuronal debris (Herbo-
mel et al., 1999, 2001; Peri and Nusslein-Volhard, 2008).
Pioneering studies by Philippe Herbomel showed that coloni-
zation of the CNS by early macrophages, which are microglial
precursors, during early development involves a tyrosine
kinase receptor named macrophage-colony stimulating factor
receptor (CSF1R), a key regulator of the myeloid lineage. In
a zebrafish mutant for the Csf1r gene these early macrophages
initially fail to reach the CNS, although later colonization of
the CNS by microglia appears to take place. Because zebrafish
have two homologs of Csf1r, it is possible that the second
receptor is sufficient for eventual microglial development
(Herbomel et al., 2001). In Csf1r knock out mice microglia
fail to develop indicating that Csf1r-dependent microglia
development is conserved between fish and mammals (Gin-
houx et al., 2010). It is unclear how Csf1r signaling exactly
controls microglial development, as this appears to differ
from development of other myeloid lineages. Additionally, a
recent study shows the requirement for Csf1r signaling in
microglial proliferation in mouse disease models (Gomez-Nic-
ola et al., 2013). Although the role of Csf1r in microglial
proliferation has not been investigated in adult zebrafish this
highlights the potential strength of zebrafish as a model to
discover concepts directly relevant to mammalian and disease
biology (Gomez-Nicola et al., 2013; Wang et al., 2012).
Astrocytes are highly abundant glial cells in the mam-
malian CNS, and although they are of ectodermal origin,
they have immunological capabilities as well (Gimsa et al.,
2013). They are often identified by their high expression lev-
els of the intermediate filament glial fibrillary acidic protein
(GFAP). In the zebrafish brain radial glia are the main
GFAP-expressing cells (Baumgart et al., 2012; Marcus and
Easter, 1995). However, they possess properties attributed to
astrocytes as well as radial glia in mammals. Whereas mam-
malian astrocytes are stellate cells with multiple processes,
zebrafish radial glia cell bodies are localized at the ventricle
with a single long process spanning the brain, more reminis-
cent of mammalian radial glia. As well, they share the strong
neurogenic potential with mammalian radial glia. Typical
properties shared with mammalian astrocytes include gluta-
mate re-uptake from the synaptic cleft by the glutamate trans-
porter Glt-1 (McKeown et al., 2012). Additionally, in an
adult zebrafish neuronal injury model radial glia respond in a
manner similar to mammalian astrocytes (Baumgart et al.,
2012; Goldshmit et al., 2012; Kroehne et al., 2011).
Thus, although zebrafish radial glia show neurogenic
potential and morphology characteristic of mammalian radial
glia, they also show functional properties of mammalian
astrocytes, suggesting they are partly functional equivalents of
mammalian radial glia as well as astrocytes.
In Vivo Cell Biology in the Zebrafish
Recent developments in fluorescent imaging technology and
the generation of transgenic zebrafish expressing fluorescent
proteins labeling specific proteins, organelles and cells of
interest make the zebrafish an increasingly powerful model
organism (Fig. 1E,F). The development of effective genome
editing strategies allows creation of virtually any type of
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genetic modification. We will highlight how combinations of
these developments have led to basic insight in disease related
processes, some of which have turned out to be of direct clin-
ical use. This will illustrate the specific advantages of this
model system and the expected benefit of using these models
in the context of CNS disease.
Transgenic zebrafish have been very useful for functional
genetic research by determining the effect of tissue-specific
overexpression of genes of interest. Additionally, transgenic
fluorescent reporter lines, labeling specific cell types or tissues
using various fluorescent protein (FP) derivatives, is revolutio-
nizing our understanding of in vivo cell biology. Initial experi-
ments were directed at expressing green fluorescent protein
(GFP)-tagged proteins to label a particular cell type, includ-
ing different immune cell types allowing live imaging of their
function in vivo (Long et al., 1997; Meng et al., 1997; Moss
et al., 1996). For example, myeloperoxidase driven GFP
(mpx-GFP) labels neutrophils, macrophage-expressed gene 1
(mpeg1)-driven GFP labels all mononuclear phagocytes
including microglia, whereas apolipoprotein E (ApoE) more
specifically labels microglia (Ellett et al., 2011; Peri and
Nusslein-Volhard, 2008; Wittamer et al., 2011).
To target transgenes to specific cell types one can search
and optimize a minimal promoter region yielding potent
expression in the cell type of choice. Such promoters often
lack all up and downstream regulatory elements to achieve a
faithful representation of the actual expression pattern of the
gene or cell type of choice. Other approaches have been
developed making it feasible to increase the reporter reper-
toire substantially. BAC-recombineering takes advantage of
recombination in bacteria to insert a sequence of choice into
a BAC-clone. By targeting an FP directly behind the ATG
translational start site of the gene of choice in a BAC contain-
ing the promoter but also more distant regulatory sites, the
physiological expression of this gene can be captured (Buss-
mann and Schulte-Merker, 2011). Hereby the need for initial
identification of the required promoter region of the gene is
circumvented. Additionally BAC-recombineering allows rela-
tively straightforward creation of multiple reporter genes rap-
idly. Therefore, this would facilitate the creation of new
lineage or activation-state specific reporter lines, for example
for newly identified microglial specific genes for which mini-
mal essential promoter regions have not yet been identified
(Wieghofer et al., 2015).
Nowadays many types of FPs are available with diverse
spectral properties, and localization signals, allowing quantita-
tive in vivo visualization of organelles, subcellular processes
including ionic fluctuations, activity of signal transduction
pathways and macromolecular structural alterations (Aker-
boom et al., 2013; Hocking et al., 2013; Shaner et al., 2005).
For example genetically encoded calcium indicators (GECIs),
such as Gcamp, have been optimized and used to study neu-
ronal circuits in the zebrafish (Akerboom et al., 2013; Chen
et al., 2013; Muto et al., 2011). Recently, Hochbaum et al.
(2014) have developed voltage indicators, which can be used
for optical electrophysiological studies. In addition to
“normal” FPs, there also is a repertoire of photoconvertible
proteins available that allow switching colors of FPs from
green to red (e.g., kaede, dendra) or from a dark state to an
active fluorescent state (photoactivatable GFP, PA-GFP;
Adam et al., 2014; Ando et al., 2002). This allows for spatio-
temporal lineage tracing, which will be discussed later. Zebra-
fish with several of these transgenic markers can be crossbred
relatively easily. This yields a virtually endless combination of
transgenic reporters. By using combinations of nuclear-,
membrane-, and cytoplasmic FPs, with only three colors, 9
different cell types could in principle be labeled at the same
time, and imaged at high spatiotemporal resolution in the liv-
ing brain (Bussmann and Schulte-Merker, 2011; Suster et al.,
2009). Alternatively, several subcellular processes could be
imaged in the same transgenic fish. In all, the development of
FPs with diverse properties allows spatiotemporal labeling in
vivo at the structural, cellular, subcellular and functional level.
Substantial knowledge on human neuropathology has
come from immunohistochemistry using formaldehyde-fixed,
paraffin embedded tissue stained for hematoxylin/eosin
(H&E) or antibodies thus marking disease specific hallmarks.
In contrast, what we learn about in vivo mechanisms in zebra-
fish is generally based on monitoring of cell-specific expres-
sion of fluorescent proteins. Using live imaging one can
monitor events as they occur in vivo. It is sometimes unclear
what these features would look like in fixed tissue, preventing
direct comparisons and extrapolation of possibly relevant
findings in vivo. Thus biological events that are rarely found
in a specific snapshot in fixed tissue, are more easily identified
by long-term video microscopy (Hosseini et al., 2014; van
Ham et al., 2014). Additionally, by correlated microscopy
imaging live events and static images can be combined thus
allowing the extrapolation of biological processes to conven-
tional histopathology (Sjollema et al., 2012). This makes it
easier to address more basic fundamental questions in in vivo
models and translate new meaningful hypotheses to disease
mechanisms.
In vivo studies can yield unexpected insight and discov-
eries that would likely be missed in studies using immunohis-
tochemistry or other techniques that do not provide
information about dynamic processes. We will highlight
insights and discoveries related to immune cell development
and function, to indicate the type of mechanistic insight that
can be derived. Second, we will highlight how zebrafish mod-
els can lead to clinically applicable concepts and potential
drugs for translational medicine approaches. As mentioned in
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the introduction, the zebrafish has proven its value as a model
in various aspects of neuroscience, however, these are beyond
the scope of this review. Examples of these aspects include
modeling behavior and complex behavioral brain disorders in
adult zebrafish, optogenetics, understanding neurogenesis and
neuroregeneration, as well as high throughput behavioral and
neuroactive drug discovery (Baraban, 2007; Baraban et al.,
2013; Chapouton et al., 2007; Kalueff et al., 2014b; Kokel
et al., 2012; Kyritsis et al., 2014).
New Insight in Infection and Immunity From In Vivo
Studies in Zebrafish
In vivo studies in the zebrafish have resulted in new, unex-
pected insights into basic immune responses. For instance, a
zebrafish tuberculosis (TBC) infection model has allowed vis-
ualization of basic disease mechanisms in vivo with regard to
pathogen propagation, treatment resistance and genetic vul-
nerability (Adams et al., 2011; Davis and Ramakrishnan,
2009; Volkman et al., 2010). A hallmark of TBC is the for-
mation of granulomas, which were generally thought of as
static structures formed as a protective mechanism by the
host organism. Zebrafish studies, however, revealed that these
granulomas are highly dynamic structures used by the bacteria
for propagation, potentially changing the putative disease
mechanism (Davis and Ramakrishnan, 2009). Another exam-
ple shows very basic immune cell behavior that has been pre-
viously unrecognized, and is currently validated in
mammalian disease models. In a zebrafish wounding model
using transection of the tail fin, resolution of inflammation
was accompanied by reverse migration of neutrophils away
from the site of injury (Elks et al., 2011; Mathias et al.,
2006). Since then, this phenomenon has been shown in
mammalian model systems and may be relevant for human
disease biology (Buckley et al., 2006; Woodfin et al., 2011).
These examples, although they partly remain to be investi-
gated in mammals, indicate the type of unexpected insights
found by unbiased in vivo imaging experiments that could
alter the view on the roles of behavior of immune cells in
disease.
A recent elegant example in which in vivo imaging was
used to elucidate a complex multi-organ feedback loop driv-
ing the increased production of granulocytes in response to a
cerebral infection was is the study by Hall et al. (2012). By
genetic and pharmacological manipulation, and live imaging
they showed that in zebrafish larval brains infected with Sal-
monella bacteria, macrophages secrete granulocyte colony
stimulating factor (Gcsf ) into the blood. Subsequently they
showed that Gcsf receptor activation in the hematopoietic tis-
sue induces expression of the transcription factor C/ebpb,
which then drives expression of nitric oxidase Nos2a, control-
ling proliferation of HSCs required for the differentiation of
new granulocytes (Hall et al., 2012). Although these effects
were known already as separate processes, the use of in vivo
imaging in this zebrafish experiment allowed for the connec-
tion between these separate processes, thereby elucidating a
complex multi-tissue signaling mechanism in a single study.
Several immune deficiencies with defects in specific
hematopoietic lineages have been modeled using zebrafish
mutant for homologs of human disease genes. By imaging
leukocyte behavior in these mutants better understanding of
the functional effect of these mutations on leukocyte behavior
has been achieved (Deng et al., 2011; Jones et al., 2013; Wal-
ters et al., 2010). Good examples have been provided for
Wiskott-Aldrich syndrome (WAS) and X-linked neutropenia
(XLN), which are immunodeficiencies caused by mutations
in the WASp gene resulting in defective control of the small
GTPase Cdc42. Depending on the mutation, this can lead to
diverse neutrophil phenotypes ranging from defective genera-
tion of neutrophils up to altered chemotaxis and phagocytic
capacity. By expression of human disease variants of WASp in
a zebrafish background lacking functional WASp, Jones et al.
(2013) observed indeed differential effects on leukocyte func-
tioning, the capacity and generation of neutrophils, chemotac-
tic responses to wounding, and the phagocytic capacity of
macrophages. These studies thus allow testing of clinically rel-
evant mutations and variants of known immunodeficiencies,
to gain a detailed in vivo understanding of defects in leuko-
cyte 3-dimensional migratory behavior that may not be appa-
rent in tissue culture models.
Novel Insights in Microglial Phagocytic Responses
Phagocytosis is a key function of immune cells in health and
disease. Many brain diseases involve extensive cell death, but
how dying neurons are cleared from the CNS has proven
hard to visualize, partly because the process is thought to be
very efficient. Many components of the engulfment machin-
ery, which are involved in finding, recognizing and engulfing
dying cells, and in the subsequent processing of ingested
material, have been identified, but how this machinery pre-
cisely operates within the complex brain tissue is poorly
understood in vivo (Nagata et al., 2010; Ravichandran and
Lorenz, 2007; Reddien and Horvitz, 2004).
In order to study genes involved in control of engulf-
ment in the brain in vivo, we developed a transgenic zebrafish
reporter line to label apoptotic cells (van Ham et al., 2010).
Fluorescently tagged annexin V (A5) protein, is widely used
to detect cell death, by binding with high affinity to phospha-
tidylserine (PS), which is exposed on the plasma membrane
in apoptotic cells (Reutelingsperger and van Heerde, 1997).
We created a secreted version of A5 (secA5), to achieve label-
ing of PS exposure in dying cells in vivo (van Ham et al.,
2010). Subsequently, by intravital microscopy in secA5-
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transgenic zebrafish we visualized how dying neurons are
engulfed by microglia in living brains (van Ham et al.,
2012). Additionally, by visualizing defective engulfment in
vivo, we show that the guanine nucleotide exchange factor
Elmo1 (Engulfment and Cell Motility protein 1) is needed
for completion of engulfment after recognition of the dying
cell, via regulation of actinomyosin dynamics in the forma-
tion of the phagocytic cup (van Ham et al., 2012). Around
the same time Elmo1 was shown to play a role in phagocytic
processes required for adult neurogenesis in mice, suggesting
this gene may indeed play a role in engulfment under physio-
logical conditions (Lu et al., 2011). More recently, Mazaheri
et al. (2014) have used transgenic secA5 expression in live
imaging studies as well to visualize PS exposure and clearance
of dying neurons. In their study they use secA5 labeling of
dying neurons to study the genes bai1 and tim4, previously
implicated in vitro in recognition and adhesion of apoptotic
cells (Kobayashi et al., 2007; Miyanishi et al., 2007; Park
et al., 2007). They show that the in vivo functions of these
two genes, is actually different from their function in vitro, as
bai1 and tim4 control phagosome formation around dying
neurons and stabilization of this phagosome. Together these
studies clearly show how in vivo imaging data can assist in
achieving a molecular level of understanding in vivo mecha-
nisms involved in engulfment. It will be interesting to deter-
mine how the role of these genes extends to mammals.
Second, these studies illustrate that the development of new
fluorescent reporters can directly facilitate research into cellu-
lar and even subcellular processes by gaining truly unprece-
dented in vivo resolution. Furthermore, unexpected behavior
of immune cells provides instructive functional hypotheses for
future experiments to test the relevance of phagocytosis
behavior in mammalian models.
Before phagocytic cells can perform their task they need
to migrate toward the area where they are needed, attracted
by chemokines and other cues, and it is critical to understand
how and what signaling pathways govern recruitment of these
immune cells to specific brain areas. An initial clue of the
intercellular signaling mechanisms involved in recruiting
microglia to injury comes from a live imaging study in zebra-
fish by Sieger and coworkers. In a laser mediated neuronal
injury model neurons show glutamate receptor (NMDAR)
activation leading to Ca21 influx, which causes ATP-
dependent microglial migration through purinergic P2Y12
activation (Sieger et al., 2012). Similar observations have
been made for mammalian microglia recently. Eyo et al.
(2014) showed that during kainate-induced seizures in mouse
brain slices and in vivo, glutamate-induced microglial
responses involve NMDA receptor-dependent Ca21-influx,
followed by ATP release and activation of microglial P2Y12.
Interestingly, the same issue of the journal contained a second
study that demonstrated that NMDAR activity results in
ATP-dependent mouse microglial responses (Dissing-Olesen
et al., 2014). These examples clearly show that fundamental
biological functions and processes regarding microglia in the
CNS are highly conserved. In addition to these studies on
microglia responses to wounding, Li et al. (2012) used in
vivo imaging to show that microglia are induced to contact
highly active neurons and decrease their spontaneous firing.
Again, these type of conceptual findings may pave the way
for more focused studies in mice.
Studying Immune Responses in Zebrafish Models
for CNS Disease
Several studies have shown that zebrafish can be used to study
CNS disorders, such as neurodegenerative diseases and epi-
lepsy. For example Paquet and colleagues generated a zebra-
fish model for frontotemporal dementia (FTD) and
Alzheimer’s disease (AD) by transgenic overexpression of
mutant human tau resulting in cell death and disease related
tau-phosphorylation (Paquet et al., 2009). Polyglutamine
inclusions associated with Huntington’s disease have also been
induced in the zebrafish (Schiffer et al., 2007). More recently
loss of function of Tdp-43, involved in amyotropic lateral
sclerosis and FTD, was shown to result in motor neuron
axonopathy in the zebrafish (Schmid et al., 2013). Addition-
ally, the zebrafish has been used successfully in studies on
other brain conditions including genetically inherited epilepsy
known as Dravet syndrome, psychiatric disorders and neuro-
developmental disorders (Kalueff et al., 2014a; Norton,
2013). Immune cell behavior was not the aim of any of these
studies, but it would be interesting to compare in these mod-
els how immune cells respond to the different disease
contexts.
Recently, we have used nitroreductase (NTR)-mediated
ablation to specifically induce neuronal cell death in the
zebrafish brain (van Ham et al., 2014, 2012). Nitroreductase
is a bacterial enzyme known as nsfB, which can convert the
antibiotic metronidazole into a DNA crosslinking agent, caus-
ing programmed cell death. Transgenic expression of nsfB/
NTR has been successfully used in zebrafish to study regener-
ation after ablation of pancreas, heart and other tissues
(Curado et al., 2007; Pisharath et al., 2007). By applying
brain-specific expression of nitroreductase we showed that
macrophages and microglia, clear dead neurons at the earliest
stages after induction of neuronal cell death whereas only
microglia dominate at later stages. Interestingly, animals
recover from damage completely after ablation at larval stages,
even after multiple ablations. The recovery phase involves
programmed cell death of phagocytic immune cells, which
are cleared by microglia. This is reminiscent of immune cell
behavior upon wounding, where immune cells also undergo
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programmed cell death in a process known as resolution of
inflammation (Serhan and Savill, 2005). We also found that
all phagocytes that have engulfed neuronal debris are positive
for a marker that labels microglia as well as macrophages,
whereas only a subset of phagocytes showed activity of the
microglia-specific ApoE-promoter (van Ham et al., 2014).
This indicates that peripheral macrophages and resident
microglia are recruited to brain injury in zebrafish, and
reveals that these two cell types have different roles during
their response to neuronal cell death. Another study used
nitroreductase (NTR)-mediated ablation in sensory peripheral
neurons and showed recovery after ablation in these neurons,
which seems to require the presence of peripheral glial cells
(Pope and Voigt, 2014). This suggests that depending on the
location of neuronal cell death, different cell types are
involved in recovery and that NTR ablation can be used to
understand immune maintenance of different types of neuro-
nal tissue.
Several other ways of inducing transgenic targeted cell
death include expression of the fluorescent protein KillerRed,
which upon irradiation with green light can induce oxidative
stress-mediated cell death (Teh et al., 2010), and thymidine
kinase, which can convert ganciclovir into a cytotoxic agent,
killing proliferative cells in particular (Lalancette-Hebert
et al., 2007). Such techniques can be used to damage tissues
in different ways than NTR, to test if different causes and
types of cell death yield the same immunological outcome.
Alternatively, these techniques can also be used to ablate spe-
cific immune cell lineages, to identify their corresponding
functions (Petrie et al., 2014).
Many disease and injury model studies in zebrafish
focus on embryos and larvae because of their transparency
and small size amongst others. Adult zebrafish models have
been developed as well, applying various types of invasive
injury including a telencephalic stabwound, spinal cord
lesions, and injection of excitotoxic agents (Alfaro et al.,
2011; Kroehne et al., 2011; Munzel et al., 2014; Skaggs
et al., 2014; Vajn et al., 2014). Alternatively, these paradigms
can often be applied to larvae as well. Adult zebrafish are par-
ticularly useful to study adult neuroregeneration and may
allow assessing whether findings in larval brains apply to
adult brain as well, which may better predict their effect in
adult mammals. One study using the stab wound paradigm
has shown that recovery from a brain stab wound requires an
inflammatory response for repair and regeneration to occur
(Kyritsis et al., 2012).
Future Perspectives
In view of the recent technological developments the studies
mentioned reflect only the onset of the possibilities of the
zebrafish as a model for CNS disease. The concept of a
genetic model organism is that genes can be manipulated effi-
ciently to study the function of genes for example those
involved in immune function. A considerable limitation of
application of zebrafish genetics has been the difficulty to
generate targeted or conditional knockouts. One useful possi-
bility is the use of TILLING, targeted induced local lesions
in genomes, in which ENU mutated fish are screened for
mutations in target genes to obtain mutants (Amsterdam and
Hopkins, 2006; Wienholds et al., 2003). Recently developed
genome editing techniques have made the generation of tar-
geted mutations in the zebrafish much easier. The first of
these techniques has been published in 2008 and involves the
use of zinc finger proteins (Doyon et al., 2008), followed by
recent addition of TALENs and the CRISPR/CAS system
(Huang et al., 2014; Hwang et al., 2013; Schmid and Haass,
2013). All these techniques work via the introduction of a
double strand break at a specific position in the genome.
When targeted at the right position this can cause nonsense
mutations or truncated transcripts, leading to disruption of
gene function. Although many articles published on this topic
in relation to the zebrafish are in fact proof of concept
articles, these techniques will be extensively used in the zebra-
fish to produce a wide variety of mutants. In addition to
directly disrupting gene function, these techniques also allow
targeted insertion of DNA elements into the genome (Auer
and Del Bene, 2014; Auer et al., 2014). Hereby, knock-in
animals can be generated, expressing for example FPs from a
targeted locus, and the generation of conditional mutants
should be possible in combination with the Cre-lox system
mentioned below. Thus, these developments have established
a versatile genetic toolbox well matched to available
approaches in mouse genetics.
Although these new reverse genetics techniques allow
creation of mutants, the strength of unbiased forward genetic
screening is still appealing. The availability of the sequence of
the complete zebrafish genome, the reduced costs and the
incredible throughput of massively parallel sequencing
approaches greatly facilitates forward screening efforts. An
illustrative example of how an ENU mutagenic screen in
zebrafish can yield insight in concepts of microglial activity
comes from a recent effort to discover new genes essential for
microglial function. Shiau and colleagues described that one
of the identified mutants showed a complete lack of microglia
in the CNS caused by loss of function of the NOD-like
receptor nlrc3-like gene (Shiau et al., 2013). NOD-like recep-
tors (NLRs) are cytoplasmic pattern recognition receptors,
with important regulatory function in immune cell activity
(Saxena and Yeretssian, 2014). Using genetics, live imaging
and vital dyes the Shiau et al. (2013) showed that nlrc3-like
normally prevents inflammatory activation in microglia dur-
ing their journey to the brain. Without functional nlrc3-like,
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the microglial precursors show an inflammatory, distracted,
phenotype preventing them from reaching the brain. Interest-
ingly, the authors did find neutrophils in the brain, consistent
with systemic inflammation (Shiau et al., 2013). One concept
derived from recent studies on microglia is that they are
under strong inhibitory control, which when lost, can lead to
toxicity of microglia toward neurons (Biber et al., 2007; Car-
dona et al., 2006; Ransohoff and Perry, 2009). The study on
nlrc3-like very elegantly, although indirectly, shows the con-
cept of a need for inflammatory suppression of immune cells.
The homolog of nlrc3-like has not been identified in mam-
mals, but the protein is very similar to human Nlrc3, and it
will be interesting to determine the function of mammalian
Nlrc3 and other NLRs in microglia. In fact, recent studies
linked activation of another NLR, NLRP3, in microglia by
amyloid-beta to development of AD (Heneka et al., 2013).
A key issue in neuroimmune research concerns the indi-
vidual contributions and roles of different types of immune
cells in CNS disease. Fate mapping has been used extensively
by embryologists to track distribution of embryonic tissues in
older animals by for example dye injections, which allowed
important insights in developmental biology. Nowadays,
single-cell fate mapping techniques, known as lineage tracing,
allow detailed single cell insight into cellular origins and distri-
bution which can be combined with intravital imaging. For
example Cre recombinase-mediated lox recombination is gen-
erally used in mice to generate tissue specific- or conditional
genetic knockouts (Sauer, 1998). The bacteriophage gene Cre
is expressed in a specific cell type, where it can excise a genetic
element based on two flanking genetic elements known as loxP
sites. When using Cre, fused to an estrogen receptor fragment
(ERT2) the activity of Cre can be induced via treatment with
tamoxifen to temporally control Cre activity. In combination
with fluorescent proteins CreERT2 can be used to permanently
switch on or off expression of a specific fluorescent protein in a
given tissue allowing creation of multicolor lineage tracing, as
was used in the brainbow mice and zbow zebrafish (Livet et al.,
2007; Mosimann et al., 2011). In addition to fluorescent pro-
tein expression, this technique can be used to switch genes on
or off in cell type specific manner, allowing the creation of con-
ditional knockouts in zebrafish. An example of how this can be
used in the context of neuronal injury is shown in a recent
study by Kroehne et al. (2011). They showed in adult zebrafish
that radial glial cells contribute to new neuronal tissue in
response to a telencephalic stab wound by using a radial glial
expressed CreERT2. In addition to tracking radial glia cells,
such a system could as well be used in the zebrafish to study the
origin and fate of immune cells upon damage in the brain. This
would allow us to address questions related to the individual
contributions of separate populations of macrophages and
microglial cells.
Additional questions that can be studied using these
approaches for example in combination with an ablation model
are related to where specific immune cells come from and
where they eventually go to. Is there local or more distant
recruitment of microglia, or is there recruitment of peripheral
immune cells? Our recent study using in vivo and electron
microscopy suggests that peripherally derived macrophages can
enter or exit the brain via the olfactory nerve in the nasal cavity
(van Ham et al., 2014). Although this route has been shown in
histological sections in mouse models (Kaminski et al., 2012),
it is virtually impossible to capture using live imaging in mice.
Other possible routes, which can be easily imaged, include the
zebrafish choroid plexus which is formed within 6 days after
fertilization (Garcia-Lecea et al., 2008) and the BBB, which is
formed within the first few days after fertilization (Fleming
et al., 2013). By using lineage tracing techniques, these ques-
tions can be conclusively addressed in vivo.
Recently, many comprehensive studies have been pub-
lished showing transcriptome analyses of microglia in mouse
models for neurological diseases using microarrays and RNA
sequencing (Butovsky et al., 2014; Chiu et al., 2013; Hick-
man et al., 2013; Orre et al., 2014). Additionally, genetic
studies in humans have identified tremendous numbers of
potential disease genes and variants. For both these type of
data sets zebrafish provides a great platform to analyze expres-
sion patterns and test the effect of manipulating genes on
immune function or disease progression before moving to
mammalian systems or identifying them as causative variants
in disease. For example, in situ mRNA hybridization of can-
didate genes in zebrafish is a relatively straightforward way to
identify relevant expression patterns. Similarly, BAC recom-
bineering can be used as an in vivo alternative to in situ RNA
detection to identify dynamic expression patterns (Bussmann
and Schulte-Merker, 2011). In fact BAC recombineering was
applied to create a reporter for expression of P2Y12 marking
microglia in zebrafish (Sieger et al., 2012). This gene was
later found as a highly enriched microglial gene in several
mouse transcriptome studies mentioned (Beutner et al., 2013;
Butovsky et al., 2014; Chiu et al., 2013; Hickman et al.,
2013). Subsequently mutants can be created for such a gene,
and virtually any combination of the techniques mentioned,
including tissue-specific conditional markers or loss of func-
tion. Taken together with technical advances mentioned
above, this suggests that also for genes found in brain disease
models by large scale genetic approaches, functional analysis
in zebrafish is becoming a useful starting place for functional
genomics and to determine the function of these genes.
Small Molecule Screening and Drug Discovery
Another important aspect of zebrafish is their suitability for
high-throughput drug screening. Pioneering studies by
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Peterson and colleagues in 2001 showed in zebrafish embryos
that small molecules, efficiently absorbed from the surrounding
liquid, can induce very specific developmental phenotypes
(Peterson et al., 2000). Because of their small size, zebrafish
embryos and larvae can be kept in 96-well plates. This, in com-
bination with the easiness of treatment with chemical com-
pounds (addition of the compound to the medium) makes
them highly suitable for high-throughput drug screens, of
which some have already led to direct clinical applications. The
prostaglandin derivative dmPGE2, initially identified in zebra-
fish as a drug that increases the number of HSCs has been
approved for phase I clinical trials to enhance engraftment of
HSC transplantation in leukemia patients (Goessling et al.,
2011; North et al., 2007). Another compound, lenaldekar
(LDK), identified in a zebrafish small molecule screen for selec-
tive elimination of immature T cells, may be a new drug for
treatment of T cell leukemia (Ridges et al., 2012). Interestingly,
because multiple sclerosis involves an over-activation of T cells
as well, they tested this new drug in an MS mouse model
(EAE) showing a reduced disease severity due to prevention of
expansion of the T-cell population (Cusick et al., 2012). This
also shows that although there are no zebrafish models for auto-
immune diseases, yet, zebrafish studies can have direct relevance
for research on autoimmunity. A recent example of a novel
drug found in zebrafish and moving toward clinical application
is based on the drug dorsomorphin, which causes dorsalization
in zebrafish embryos and inhibits BMP signaling. Because a
fatal connective tissue disease fibrodysplasia ossificans progres-
siva (FOP) is caused by increased BMP signaling, inhibiting
this pathway could inhibit the disease process. The effectivity
of the dorsomorphin derivative in a mouse model for this dis-
ease has led medicinal chemists to develop more potent deriva-
tives of dorsomorphin that may soon be tested in early clinical
trials (Yu et al., 2008a, 2008b). These data clearly indicate that
small molecule screens in zebrafish lead to discovery of drugs
with high clinical relevance without a priori knowledge of what
drug target would be involved. Beyond these screens of disease
related phenotypes, and interesting in the context of this review,
high-throughput behavioral drug discovery has revealed already
many new neuro-psychoactive compounds (Kokel et al., 2010,
2012). Although the exact mechanisms of some of the drugs
found are unknown, finding new drug classes is an Achilles heel
in drug discovery, as most of the currently known drugs were
found serendipitously (Schlueter and Peterson, 2009).
In the context of this review, small molecule screening
could be applied to transgenic fluorescent reporter lines marking
brain immune cells to find small molecules that alter intensity or
localization of these reporters in vivo. Two recent examples of
screens directed at finding drugs that alter immune cell behavior
show that such an approach is feasible. In the first study they
identified small molecules that inhibit retrograde migration of
neutrophils in a zebrafish tailfin wounding model (Robertson
et al., 2014). Interestingly, drugs found in this screen had the
same effect on human neutrophils suggesting these responses are
highly conserved. In a second study they identified small mole-
cules that inhibits inflammatory recruitment of immune cells to
killing of lateral line neuromast cells by copper sulfate (d’Alen-
con et al., 2010; Wittmann et al., 2012). Imaging fluorescent
phenotypes in the brain in 3D has been difficult in a high
throughput fashion, mainly due to out of focus light, and the
general low throughput nature of confocal microscopy. Recent
developments have also started to overcome these hurdles by
designing 96 wells plates to mount larvae in the right position
for imaging, building microfluidics systems for automated con-
focal imaging and automated quantitative analysis of the imag-
ing data (Pardo-Martin et al., 2010; Peravali et al., 2011).
Therefore, in addition to using the models described throughout
this chapter for annotation of gene function, and elucidation of
disease mechanisms, the possibility of small molecule screening
in zebrafish has become a mainstay in novel bioactive small mol-
ecule discovery (Zon and Peterson, 2005).
Concluding Remarks
A recent zebrafish review has suggested that zebrafish models
should prove themselves by discovering new biology instead of
merely modeling disease processes (Lieschke and Currie,
2007). Based on progress described above this step has clearly
been taken. Although many aspects of zebrafish biology with
regard to neuroimmunology are highly conserved, obviously,
there are differences between the human or mammalian and
fish immune system. For example zebrafish do not have lymph
nodes. In contrast, zebrafish do have MhcII expressing antigen
presenting cells suggesting they have functional equivalents of
lymph nodes elsewhere. Also, hardly any of the antibodies
used in humans and mice as markers for different immune cell
types and inflammatory phenotypes are compatible with the
zebrafish. Fortunately, transgenic markers are as versatile as
antibodies and can be used for the same purposes equally well.
Therefore, for basic questions about the functioning of the
immune system such minor differences in mechanism or
approach do not have to be limiting. We argue that recent
unexpected discoveries and technical advances create a niche
for the zebrafish in the field of neuroimmunology by allowing
an unprecedented view into cellular mechanisms of immune-
maintenance and repair in the brain with the realistic possibil-
ity of eventually extrapolating basic findings to the clinic.
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